NeuralCipher Open access
LRRK2 and membrane trafficking: nexus of Parkinson's disease.
PMID: 31383252
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
1.241 articles found
“Parkinson LRRK2” Clear search
Source record
Synthesis and Preliminary Evaluation of [<sup>11</sup> C]GNE-1023 as a Potent PET Probe for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease.
DOI: 10.1002/cmdc.201900321PMID: 31365783
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Altered reward-related neural responses in non-manifesting carriers of the Parkinson disease related LRRK2 mutation.
DOI: 10.1007/s11682-018-9920-2PMID: 29971685
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson's disease.
DOI: 10.4155/fmc-2018-0484PMID: 31517532
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.
DOI: 10.1016/j.brainres.2019.146342PMID: 31330122
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Pleiotropic effects for Parkin and LRRK2 in leprosy type-1 reactions and Parkinson's disease.
DOI: 10.1073/pnas.1901805116PMID: 31308240
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Recent Developments in LRRK2-Targeted Therapy for Parkinson's Disease.
DOI: 10.1007/s40265-019-01139-4PMID: 31161537
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson's Disease and Other Neurodegenerative Disorders.
DOI: 10.1021/acsmedchemlett.9b00216PMID: 31223436
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium.
DOI: 10.1016/j.jns.2019.05.016PMID: 31129265
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
DOI: 10.1016/j.neulet.2019.05.014PMID: 31085292
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes.
DOI: 10.1016/j.nbd.2019.05.006PMID: 31085228
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
<i>α</i>-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease.
DOI: 10.1002/acn3.772PMID: 31211166
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.